West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.79, $0.10 better than the analyst estimate of $0.69. Revenue for the quarter came in at $324.8 million versus the consensus estimate of $321.5 million.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.

Earnings